Patents by Inventor Wolfgang Weckerle

Wolfgang Weckerle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5460975
    Abstract: The present invention concerns compounds having the general formula I ##STR1## in which R.sup.1 denotes hydrogen or hydroxy,R.sup.2 denotes hydrogen or hydroxy,R.sup.3 denotes hydrogen or alkoxy,R.sup.4 denotes hydrogen, CO.sub.2 H, SO.sub.3 H, PO.sub.3 H.sub.2 or a salt of the corresponding acid,R.sup.5 denotes CO.sub.2 H, SO.sub.3 H, PO.sub.3 H.sub.2 or a salt of the corresponding acid andR.sup.6 denotes alkoxy,their use for displacing iodothyronines from proteins binding them, as well as a method and reagent for the determination of iodothyronine in which such compounds are used.
    Type: Grant
    Filed: July 7, 1993
    Date of Patent: October 24, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Helmut Freitag, Wolfgang-Reinhold Knappe, Heino Eikmeier, Wolfgang Weckerle
  • Patent number: 5292669
    Abstract: A method of detecting hydrolase activity using as substrates the compounds of the formula ##STR1## wherein each of R.sup.1, R.sup.2 and R.sup.3 is C.sub.1 -C.sub.4 alkyl, or phenyl optionally substituted in the meta- or para- position by C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy or mono- or di-(C.sub.1 -C.sub.6)-alkylamino, or optionally substituted by an O-X group in which X is a glycosyl, phosphate or acyl moiety of a natural substrate of the corresponding glycosidase, phosphatase or esterase.
    Type: Grant
    Filed: August 10, 1992
    Date of Patent: March 8, 1994
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans-Joachim Guder, Werner Guthlein, Wolfgang Weckerle, Johann Berger, Harvey Buck, Rupert Herrmann
  • Patent number: 4966855
    Abstract: The invention provides new redox indicators and uses for these redox compounds (I): ##STR1## Wherein X is oxygen or sulphur, R.sub.1 is julolidine or tetrahydroquinoline, which can carry an alkyl radical on the nitrogen atom which, in turn, can be substituted by a sulphuric, phosphonic or carboxylic acid residues, or is (II); wherein R.sub.4 is hydroxyl or a mono- or dialkylated amino group, R.sub.5 and R.sub.6, which can be the same or different, are hydrogen, alkyl or alkoxy, R.sub.2 is hydrogen or alkyl, julolidine or tetrahydroquinoline, which can carry an alkyl on the nitrogen atom which alkyl can be substituted by sulphuric, phosphonic or carboxylic acids, or is III; wherein R.sub.5 and R.sub.6 are the same as in R.sub.1 and R'.sub.4 is hydroxyl, an amino or a mono-or dialkylated amino group, whereby the alkyl radicals can be substituted one or more times by hydroxyl, alkoxy, halogen, morpholine or a sulphuric, carboxylic or phosphonic acid residue, which acids can also be esterified, and R.sub.
    Type: Grant
    Filed: July 2, 1985
    Date of Patent: October 30, 1990
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ulfert Deneke, Werner Guthlein, Wolfgang Weckerle, Hans Wielinger
  • Patent number: 4668622
    Abstract: The present invention provides phenolsulphonphthaleinyl-.beta.-D-galactosides of the general formula: ##STR1## wherein R.sup.1 to R.sup.4, which can be the same or different, are hydrogen or halogen atoms or nitro or amino groups, R.sup.5 to R.sup.12, which can be the same or different, are hydrogen or halogen atoms or lower alkyl, hydroxyl, lower alkoxy, carboxyl or nitro groups and M.sup.+ is a proton, an alkali metal, alkaline earth metal or ammonium ion.The present invention also provides a process for preparing these galactosides and diagnostic agents containing them.
    Type: Grant
    Filed: December 13, 1984
    Date of Patent: May 26, 1987
    Assignee: Boehringer Mannheim GmbH
    Inventors: Manfred Kuhr, Rudolf Machat, Wolfgang Weckerle, Hans-Georg Batz, Rupert Herrmann, Wolfgang Kleeman, Herbert Buschek
  • Patent number: 4479962
    Abstract: The present invention provides heteroaryloxypropanolamines and pharmaceutical compositions containing them, for combating, and for the prophylaxis of, cardiac and circulatory diseases. The heteroaryloxypropanolamines of the present invention are of the general formula: ##STR1## wherein A is a bi- or tricyclic heteroaromatic radical, which is optionally partly hydrogenated, X is a straight-chained or branched alkylene chain containing 2 to 6 carbon atoms, R.sub.1 and R.sub.2, which can be the same or different, are hydrogen atoms or lower alkyl or benzyl radicals, R.sub.3, R.sub.4 and R.sub.5, which can be the same or different, are hydrogen atoms or lower alkyl, benzyl, formyl, lower alkanoyl, cyano, hydroxymethyl, lower alkoxycarbonyl or carbamoyl radicals or the divalent substituents sulfur or oxygen and R.sub.6, R.sub.7 and R.sub.8, which can be the same or different, are hydrogen or halogen atoms, lower alkyl, nitro, amino, lower alkylthio or lower alkoxy radicals or R.sub.6 and R.sub.
    Type: Grant
    Filed: August 2, 1982
    Date of Patent: October 30, 1984
    Assignee: Boehringer Mannheim GmbH
    Inventors: Fritz Wiedemann, Helmut Michel, Wolfgang Weckerle, Egon Roesch, Klaus Strein
  • Patent number: 4201773
    Abstract: A series of compounds showing high antileukemic activity against P388 murine leukemia and increased aqueous solubility due to substitution of --OH for the known --NH.sub.2 at the 3' position of the hexopyranose sugar, i.e., daunosamine.These compounds are coupled products of aglycon selected from daunomycinone, desmethoxy daunomycinone, adriamycinone and carminomycinone. These compounds are coupled at the 0-7 position of the aglycon with an .alpha.
    Type: Grant
    Filed: July 26, 1978
    Date of Patent: May 6, 1980
    Assignee: The United States of America as represented by the Department of Health, Education and Welfare
    Inventors: Derek Horton, Wolfgang Weckerle, Ernst F. Fuchs, Tak M. Cheung, Beat Winter, Roderick J. Sorenson